| | The Centers for Disease Control and Prevention (CDC) said on Monday it had ended its COVID-19 country travel health notices as fewer countries reported enough data for accurate assessments. | | | Grifols appointed an executive chairman on Monday, as the Spanish pharmaceutical company strives to recover from a pandemic-related hit and a 49% drop in its shares so far this year. | | | The U.S. Supreme Court on Monday declined to hear a challenge by Missouri and nine other states - mostly Republican-led - to President Joe Biden's COVID-19 vaccine mandate for workers in healthcare facilities that receive federal funds. | | | The U.S. Supreme Court on Monday declined to hear Biogen Inc's bid to win reinstatement of a patent on the company's blockbuster multiple sclerosis drug Tecfidera in a dispute with Viatris Inc subsidiary Mylan Pharmaceuticals Inc. | | | Norwegian Cruise Line said on Monday it was easing COVID-19 safety measures on its ships by dropping requirements for testing, masking and vaccination, as the pandemic loosens its grip on the world. | | | Shares of LogicBio Therapeutics skyrocketed on Monday after Britain's AstraZeneca's said it would buy the U.S.-based gene therapy developer at a rare 660% premium for $68 million. | | | Europe has experienced its worst bird flu crisis ever this year with nearly 50 million poultry culled, and the persistence of the virus over the summer has raised the risk of widespread infections next season, the EU's Food Safety Agency (EFSA) said. | | | Swedish geneticist Svante Paabo won the 2022 Nobel Prize in Physiology or Medicine on Monday for discoveries that underpin our understanding of how modern day people evolved from extinct ancestors at the dawn of human history. | | | Health authorities in Vietnam's Ho Chi Minh City on Monday announced the country's first case of monkeypox, the state-run Vietnamnet newspaper reported, without giving any details on the patient. | | | Roche Holding has named Matt Sause, head of Roche Diagnostics' North America region, to lead the group's diagnostics business, the Swiss drugmaker said on Monday. | | | | |